Duma N - Search Results

1

Characterization of Comorbidities Limiting the Recruitment of Patients in Early Phase Clinical Trials.

Duma N, Kothadia SM, Azam TU, Yadav S, Paludo J, Vera Aguilera J, Gonzalez Velez M, Halfdanarson TR, Molina JR, Hubbard JM, Go RS, Mansfield AS, Adjei AA. Duma N, et al. Oncologist. 2019 Jan;24(1):96-102. doi: 10.1634/theoncologist.2017-0687. Epub 2018 Nov 9. Oncologist. 2019. PMID: 30413668 Free PMC article.

2

Representation of Minorities and Women in Oncology Clinical Trials: Review of the Past 14 Years.

Duma N, Vera Aguilera J, Paludo J, Haddox CL, Gonzalez Velez M, Wang Y, Leventakos K, Hubbard JM, Mansfield AS, Go RS, Adjei AA. Duma N, et al. J Oncol Pract. 2018 Jan;14(1):e1-e10. doi: 10.1200/JOP.2017.025288. Epub 2017 Nov 3. J Oncol Pract. 2018. PMID: 29099678 Review.

3

Representation of Minorities and Elderly Patients in Multiple Myeloma Clinical Trials.

Duma N, Azam T, Riaz IB, Gonzalez-Velez M, Ailawadhi S, Go R. Duma N, et al. Oncologist. 2018 Sep;23(9):1076-1078. doi: 10.1634/theoncologist.2017-0592. Epub 2018 Apr 26. Oncologist. 2018. PMID: 29700207 Free PMC article.

4

Commentary: Race and Ethnicity in Biomedical Research - Classifications, Challenges, and Future Directions.

Idossa D, Duma N, Chekhovskiy K, Go R, Ailawadhi S. Idossa D, et al. Among authors: duma n. Ethn Dis. 2018 Oct 18;28(4):561-564. doi: 10.18865/ed.28.4.561. eCollection 2018 Fall. Ethn Dis. 2018. PMID: 30405301 Free PMC article.

5

Pompe Disease Could Mimic Exam Findings of Amyloidosis: Two Rare Diagnoses Bona Fide.

Abeykoon JP, Duma N, Tracy JA, Milone M, Go R. Abeykoon JP, et al. Among authors: duma n. Case Rep Hematol. 2018 Oct 28;2018:9615834. doi: 10.1155/2018/9615834. eCollection 2018. Case Rep Hematol. 2018. PMID: 30510819 Free PMC article.

6

Hemolytic Uremic Syndrome Associated With Escherichia coli O157 Infection in an Allogenic Stem Cell Transplant Recipient.

Vera-Aguilera J, Duma N, Gast K, Alkhateeb H, Tande A, Leung N, Hogan WJ, Kenderian SJ. Vera-Aguilera J, et al. Among authors: duma n. Mayo Clin Proc Innov Qual Outcomes. 2018 Sep 15;2(4):387-391. doi: 10.1016/j.mayocpiqo.2018.07.001. eCollection 2018 Dec. Mayo Clin Proc Innov Qual Outcomes. 2018. PMID: 30560242 Free PMC article.

7

Wang Y, Zhou S, Yang F, Qi X, Wang X, Guan X, Shen C, Duma N, Vera Aguilera J, Chintakuntlawar A, Price KA, Molina JR, Pagliaro LC, Halfdanarson TR, Grothey A, Markovic SN, Nowakowski GS, Ansell SM, Wang ML. Wang Y, et al. Among authors: duma n. JAMA Oncol. 2019 Jul 1;5(7):1008-1019. doi: 10.1001/jamaoncol.2019.0393. JAMA Oncol. 2019. PMID: 31021376 Free PMC article.

8

Sex Differences in Tolerability to Anti-Programmed Cell Death Protein 1 Therapy in Patients with Metastatic Melanoma and Non-Small Cell Lung Cancer: Are We All Equal?

Duma N, Abdel-Ghani A, Yadav S, Hoversten KP, Reed CT, Sitek AN, Enninga EAL, Paludo J, Aguilera JV, Leventakos K, Lou Y, Kottschade LA, Dong H, Mansfield AS, Manochakian R, Adjei AA, Dronca RS. Duma N, et al. Oncologist. 2019 Nov;24(11):e1148-e1155. doi: 10.1634/theoncologist.2019-0094. Epub 2019 Apr 29. Oncologist. 2019. PMID: 31036771 Free PMC article.

9

Non-Small Cell Lung Cancer: Epidemiology, Screening, Diagnosis, and Treatment.

Duma N, Santana-Davila R, Molina JR. Duma N, et al. Mayo Clin Proc. 2019 Aug;94(8):1623-1640. doi: 10.1016/j.mayocp.2019.01.013. Mayo Clin Proc. 2019. PMID: 31378236 Review.

10

Primary neuroendocrine carcinoma of the brain.

Reed CT, Duma N, Halfdanarson T, Buckner J. Reed CT, et al. Among authors: duma n. BMJ Case Rep. 2019 Sep 18;12(9):e230582. doi: 10.1136/bcr-2019-230582. BMJ Case Rep. 2019. PMID: 31537610 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

94 results

Search Page

Filters